Abbott (NYSE:ABT) announced that it is working with Women as One to launch a new physician training program. The partnership aims to train more female and underrepresented physicians to pursue clinical trial research and to help recruit clinical trial participants from historically underrepresented groups. Women as One is a nonprofit organization with a mission to […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes
Abbott (NYSE:ABT) announced today that its Xience Skypoint drug-eluting stent platform is now available globally. Xience Skypoint has received FDA approval, CE mark and PMDA approval in Japan for the broadest expansion with the availability of extended sizes of 4.5 mm and 5 mm offerings. Get the full story at our sister site, Drug Delivery Business […]
Shockwave Medical grows sales 193% in Q1
Shockwave Medical (NSDQ:SWAV) this week posted first-quarter results that beat the overall consensus on Wall Street. The Santa Clara, California-based company reported profits of $14.5 million, or 39¢ per share, on sales of $93.6 million for the three months ended March 31, for a bottom-line gain from the year prior on sales growth of 193.5%. Earnings […]
FDA approves magnetic resonance labeling for CVRx’s Barostim neuromodulation system
CVRx (Nasdaq:CVRX) announced today that the FDA approved magnetic resonance (MR) conditional labeling for its Barostim system. The Barostim neuromodulation system for treating the symptoms of heart failure now includes instructions to allow for safe MRI scans of the head and lower extremities, offering heart failure patients implanted with Barostim more diagnostic options. Minneapolis-based CVRx […]
Silk Road Medical grows sales 27% in Q1 results
Silk Road Medical (NSDQ:SILK) this week posted first-quarter results that beat the revenue consensus on Wall Street and missed on earnings. The Sunnyvale, California-based stroke treatment tech company reported losses of $16.7 million, or -48¢ per share, on sales of $28.02 million for the three months ended March 31 for sales growth of 27% compared […]
iRhythm stock soars on Street-beating Q1; C-Suite changes continue
iRhythm Technologies (Nasdaq:IRTC) posted first-quarter results that beat the consensus forecast on Wall Street and increased its outlook for the rest of the year, sending the stock up more than 10% by this morning. The San Francisco-based developer of remote external electrocardiogram monitors reported a net loss of $50.6 million, or -$1.71 per share, on […]
AtriCure beats The Street in Q1 results
AtriCure (Nasdaq:ATRC) this week posted first-quarter results that beat the overall consensus on Wall Street. The Mason, Ohio-based cardiac ablation device company reported losses of $15.2 million, or -34¢ per share, on sales of $74.6 million for three months ended March 31, for a bottom-line gain of 10.3% on sales growth of 25.8% compared with […]
Cardiovascular Systems reports 11% sales loss in Q3 results
Cardiovascular Systems (NSDQ:CSII) this week posted third-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates. The St. Paul, Minnesota-based heart device company reported losses of $9.7 million, or -25¢ per share, on sales of $56.2 million for the three months ended March 31, for a sales loss of -11.15% compared […]
AliveCor launches KardiaComplete heart health management platform
AliveCor announced today that it launched its KardiaComplete comprehensive heart health enterprise solution. Mountain View, California-based AliveCor designed the KardiaComplete platform to drive improved health outcomes and reduce the cost of cardiac care for people diagnosed with hypertension and arrhythmias, like AFib, through their self-insured employers, health insurance plans and health systems. The company said […]
Medtronic enrolls first patient in trial of Evolut TAVR system in patients with aortic stenosis
Medtronic (NYSE:MDT) announced today that it enrolled the first patient in its Expand TAVR II pivotal trial. Expand TAVR II will evaluate the self-expanding, supra-annular Evolut transcatheter aortic valve replacement (TAVR) platform in patients with moderate, symptomatic aortic stenosis (AS), a population outside of current guidelines and indications for TAVR. According to a news release, […]
Mayo Clinic’s new Apple Watch app uses AI to detect left-ventricular dysfunction
The Mayo Clinic developed a new app that transmits ECG signals from Apple Watches for AI analysis to identify heart disease. The application securely transmits ECG (electrocardiograms) signals recorded in non-clinical environments to a medical center so that the AI analysis can identify left-ventricular dysfunction, a life-threatening, asymptomatic heart disease. According to a news release, […]